Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Affiliation
Postgraduate Institute of Medical Sciences (SGPGIMS); Aarhus University Hospital; Mayo Clinic; The Dudley Group NHS Foundation Trust et alPublication date
01/02/2023Subject
Cardiology
Metadata
Show full item recordAbstract
Cardiovascular disease (CVD) risk is increased in most inflammatory rheumatic diseases (IRDs), reiterating the role of inflammation in the initiation and progression of atherosclerosis. An inverse association of CVD risk with body weight and lipid levels has been described in IRDs. Coronary artery calcium scores, plaque burden and characteristics, and carotid plaques on ultrasound optimize CVD risk estimate in IRDs. Biomarkers of cardiac injury, autoantibodies, lipid biomarkers, and cytokines also improve risk assessment in IRDs. Machine learning and deep learning algorithms for phenotype and image analysis hold promise to improve CVD risk stratification in IRDs. Copyright 2022 Elsevier Inc. All rights reserved.Citation
Misra DP, Hauge EM, Crowson CS, Kitas GD, Ormseth SR, Karpouzas GA. Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic DiseasesType
ArticlePMID
36424025Publisher
Elsevierae974a485f413a2113503eed53cd6c53
10.1016/j.rdc.2022.07.004